Butterfly Network(BFLY) - 2025 Q4 - Annual Report

Financial Performance - Total revenue for Butterfly was $97.6 million in 2025, up from $82.1 million in 2024, representing a year-over-year increase of approximately 19%[26] - The company incurred net losses of $77.1 million in 2025 compared to $72.5 million in 2024, indicating a loss increase of about 6.3%[26] - The company incurred net losses of $133.7 million, $72.5 million, and $77.1 million for the years ended December 31, 2023, 2024, and 2025, respectively, with an accumulated deficit of $879.2 million as of December 31, 2025[132] - Approximately 11% of the company's revenue in 2025 was generated from sales to a single customer[132] - Approximately 21% of total revenue in 2023 was generated from international customers, with expectations for future revenue growth from international sources[146] Product and Technology - Butterfly's Ultrasound-on-Chip™ technology allows for a 3D-capable ultrasound machine on a chip the size of two postage stamps, enhancing portability and accessibility[27] - The Butterfly iQ3 device, launched in February 2024, has shown impressive market uptake, contributing to increased penetration in the ultrasound market[41] - The Butterfly enterprise platform integrates ultrasound hardware and workflow software, enhancing clinical decision-making and improving efficiency across health systems[63] - Butterfly's semiconductor technology differentiates its products from competitors, enabling whole-body scans without reliance on lead-based piezoelectric crystals[84] - The company is engaged in the development of ultrasound imaging solutions using its Ultrasound-on-Chip™ technology, which is critical for its market positioning[135] Market and Expansion - The addressable market for Butterfly's solutions is estimated to exceed $100 billion, targeting over 40 million healthcare practitioners globally[40] - The company aims to expand its total addressable market by an additional $325 billion through Butterfly Embedded™ co-development opportunities[44] - Butterfly's new HomeCare Services Business, introduced in March 2024, focuses on managing chronic conditions outside the hospital, aiming to reduce readmissions[47] - The company has placed its devices with hundreds of NGOs to deliver medical imaging to underserved communities, supported by a $5 million grant from the Gates Foundation for a POCUS deployment in sub-Saharan Africa[75] - For the fiscal year ended December 31, 2025, a substantial majority of revenues were derived from U.S. customers, with devices deployed across approximately 100 countries[76] Sales and Marketing - The company must continue to develop its sales and marketing organization to achieve market awareness and commercial success for its products[169] - The company relies on the success of its sales and customer acquisition strategies, emphasizing the importance of maintaining high service quality to retain and attract users[143] - The company faces challenges in managing its sales force and increasing product sales at acceptable rates, which could adversely affect future revenue[172] - There is a risk of reduced sales volume if the company fails to establish and maintain adequate sales and marketing capabilities, potentially leading to a material adverse effect on operating performance[173] Regulatory and Compliance - The company is subject to extensive global laws and regulations regarding data privacy, including HIPAA and GDPR, which impose significant compliance burdens[126] - The company’s future revenue generation is heavily dependent on the successful commercialization of its products and maintaining regulatory compliance[134] - The company’s medical devices are classified as Class II devices under FDA regulations, requiring pre-market notification for commercial sales[114] - Regulatory compliance is critical, as failure to obtain necessary authorizations or maintain quality standards could limit market acceptance and disrupt operations[175] - The company must ensure compliance with anti-bribery laws, as violations could lead to severe penalties and operational disruptions[181] Intellectual Property - As of February 25, 2026, the company owned approximately 665 issued patents and pending patent applications, with expected expiration dates ranging from 2030 to 2046[209] - The company relies on patent protection, trademarks, copyrights, and trade secrets to maintain its competitive advantage, but these protections may be limited and not adequately enforceable[210] - The company may face significant litigation costs if sued for infringing third-party intellectual property rights, which could adversely impact its business operations[221] - The company may not be able to prevent third parties from practicing its inventions outside the United States, limiting its competitive edge in those markets[212] - The company has entered into a Co-Development and Licensing Agreement with Midjourney for its Ultrasound-on-Chip™ technology, which includes annual license fees and milestone payments[220] Employee and Operational Insights - The company employs approximately 220 employees as of January 31, 2026, reflecting its growth and operational capacity[28] - The company offers a competitive total rewards package, including market-competitive base salaries, annual target cash bonuses, and long-term equity incentives[87] - Employee health coverage includes 100% employer-funded medical, dental, and vision insurance, along with a health savings account for out-of-pocket expenses[88] - The company employs approximately 70 people globally in sales, sales support, and marketing as of December 31, 2025[72] - As of January 31, 2026, the company had approximately 220 employees, with 180 located in the United States and 40 outside the United States[86] Risks and Challenges - The company faces competition from established manufacturers with greater resources, which may impact its ability to compete effectively in the market[142] - The company faces risks associated with launching new products, including potential delays in product launch dates due to development or manufacturing challenges[144] - The company relies on a single supplier, TSMC, for key components, which poses risks if TSMC fails to meet its obligations or if geopolitical tensions disrupt supply[154][156] - Unfavorable global economic conditions, including inflation and economic downturns, could weaken demand for products and impact financial performance[178] - Increased cybersecurity threats and vulnerabilities pose risks to the company's systems and data, potentially leading to significant business disruptions and reputational damage[200]